Prevalence of Opioid Dispensings and Concurrent Gastrointestinal Medications in Quebec
BACKGROUND: Opioids are frequently prescribed for moderate to severe pain. A side effect of opioid usage is the inhibition of gastrointestinal (GI) motility, known as opioid-induced bowel dysfunction (OBD). OBD is typically treated prophylactically with laxatives and/or acid suppressants.
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2008-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/2008/435738 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832568336966221824 |
|---|---|
| author | Rachel E Williams Nevzeta Bosnic Carolyn T Sweeney Ashlee W Duncan Kristen B Levine Michael Brogan Suzanne F Cook |
| author_facet | Rachel E Williams Nevzeta Bosnic Carolyn T Sweeney Ashlee W Duncan Kristen B Levine Michael Brogan Suzanne F Cook |
| author_sort | Rachel E Williams |
| collection | DOAJ |
| description | BACKGROUND: Opioids are frequently prescribed for moderate to severe pain. A side effect of opioid usage is the inhibition of gastrointestinal (GI) motility, known as opioid-induced bowel dysfunction (OBD). OBD is typically treated prophylactically with laxatives and/or acid suppressants. |
| format | Article |
| id | doaj-art-16d12a71eac34960a7c5914e454fd717 |
| institution | Kabale University |
| issn | 1203-6765 |
| language | English |
| publishDate | 2008-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Pain Research and Management |
| spelling | doaj-art-16d12a71eac34960a7c5914e454fd7172025-02-03T00:59:16ZengWileyPain Research and Management1203-67652008-01-0113539540010.1155/2008/435738Prevalence of Opioid Dispensings and Concurrent Gastrointestinal Medications in QuebecRachel E Williams0Nevzeta Bosnic1Carolyn T Sweeney2Ashlee W Duncan3Kristen B Levine4Michael Brogan5Suzanne F Cook6Worldwide Epidemiology, GlaxoSmithKline, Collegeville, Pennsylvania, USABrogan Inc, Ottawa, Ontario, CanadaWorldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North Carolina, USAWorldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North Carolina, USADepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USABrogan Inc, Ottawa, Ontario, CanadaWorldwide Epidemiology, GlaxoSmithKline, Research Triangle Park, North Carolina, USABACKGROUND: Opioids are frequently prescribed for moderate to severe pain. A side effect of opioid usage is the inhibition of gastrointestinal (GI) motility, known as opioid-induced bowel dysfunction (OBD). OBD is typically treated prophylactically with laxatives and/or acid suppressants.http://dx.doi.org/10.1155/2008/435738 |
| spellingShingle | Rachel E Williams Nevzeta Bosnic Carolyn T Sweeney Ashlee W Duncan Kristen B Levine Michael Brogan Suzanne F Cook Prevalence of Opioid Dispensings and Concurrent Gastrointestinal Medications in Quebec Pain Research and Management |
| title | Prevalence of Opioid Dispensings and Concurrent Gastrointestinal Medications in Quebec |
| title_full | Prevalence of Opioid Dispensings and Concurrent Gastrointestinal Medications in Quebec |
| title_fullStr | Prevalence of Opioid Dispensings and Concurrent Gastrointestinal Medications in Quebec |
| title_full_unstemmed | Prevalence of Opioid Dispensings and Concurrent Gastrointestinal Medications in Quebec |
| title_short | Prevalence of Opioid Dispensings and Concurrent Gastrointestinal Medications in Quebec |
| title_sort | prevalence of opioid dispensings and concurrent gastrointestinal medications in quebec |
| url | http://dx.doi.org/10.1155/2008/435738 |
| work_keys_str_mv | AT rachelewilliams prevalenceofopioiddispensingsandconcurrentgastrointestinalmedicationsinquebec AT nevzetabosnic prevalenceofopioiddispensingsandconcurrentgastrointestinalmedicationsinquebec AT carolyntsweeney prevalenceofopioiddispensingsandconcurrentgastrointestinalmedicationsinquebec AT ashleewduncan prevalenceofopioiddispensingsandconcurrentgastrointestinalmedicationsinquebec AT kristenblevine prevalenceofopioiddispensingsandconcurrentgastrointestinalmedicationsinquebec AT michaelbrogan prevalenceofopioiddispensingsandconcurrentgastrointestinalmedicationsinquebec AT suzannefcook prevalenceofopioiddispensingsandconcurrentgastrointestinalmedicationsinquebec |